image_alt_text
5

Arvind Natarajan, Ph.D., MBA

AIMBE College of Fellows Class of 2025
For pioneering contributions in cell and gene therapies, biologics and vaccine development, and for sustainable commercialization of clinical programs.

Arvind Natarajan Inducted into the 2025 Class of the AIMBE College of Fellows

Via AIMBE | March 31, 2025

WASHINGTON, D.C. – The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Arvind Natarajan, Ph.D., MBA, Senior Vice President of Process and Analytical Development at Iovance Biotherapeutics to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”

Dr. Natarajan was nominated, reviewed, and elected by peers and members of the College of Fellows “for pioneering contributions in cell and gene therapies, biologics and vaccine development, and for sustainable commercialization of clinical programs…. Continue reading.

...